You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014100
Mar 20141001
Apr 20141201
May 20141103
Jun 2014804
Jul 2014100
Aug 2014500
Sep 20141002
Oct 20141609
Nov 2014500
Dec 20141101
Jan 20151200
Feb 20151601
Mar 20151604
Apr 20153508
May 20151303
Jun 20152203
Jul 20152201
Aug 20152101
Sep 20154006
Oct 20151202
Nov 20153803
Dec 20153402
Jan 20168909
Feb 2016115012
Mar 20165208
Apr 20165104
May 20162603
Jun 20164307
Jul 20162502
Aug 20163505
Sep 20163501
Oct 20162703
Nov 20162200
Dec 20161201
Jan 20171602
Feb 20171300
Mar 20172801
Apr 20171400
May 20171200
Jun 2017500
Jul 20176800
Aug 20175401
Sep 20175400
Oct 20173201
Nov 20172800
Dec 20173000
Jan 20183802
Feb 20182602
Mar 20182800
Apr 20184001
May 20183402
Jun 20182800
Jul 20182800
Aug 20182600
Sep 20181400
Oct 20182402
Nov 20183800
Dec 20181601
Jan 20193705
Feb 20192802
Mar 20191500
Apr 2019700
May 2019900
Jun 20191301
Jul 2019500
Aug 2019700
Sep 2019600
Oct 20191500
Nov 20191101
Dec 20191100
Jan 2020901
Feb 20202701
Mar 20201700
Apr 20201600
May 20203200
Jun 2020801
Jul 2020900
Aug 20201400
Sep 20201201
Oct 20202200
Nov 20201501
Dec 2020400
Jan 20211100
Feb 20212100
Mar 2021200
Apr 20212200
May 2021200
Jun 2021100
Jul 2021100
Aug 2021301
Sep 2021400
Oct 20211800
Nov 20211903
Dec 20211800
Jan 2022300
Feb 20221000
Mar 2022700
Apr 2022200
May 20221600
Jun 2022600
Jul 20221600
Aug 20221200
Sep 20221100
Oct 2022700
Nov 20221300
Dec 20223000
Jan 20231301
Feb 2023800
Mar 20231000
Apr 20231300
May 2023700
Jun 20231900
Jul 2023500
Aug 20231100
Sep 20231101
Nov 2023200
Dec 20232000
Jan 2024600
Feb 2024200
Mar 2024900
Total23370145